Sentence examples for expression of an activator from inspiring English sources

The threshold (theta) discretizes the expression of an activator (u) or inhibitor (w) into discrete (qualitative) levels represented by positive integers.

Thus hearts from PKCε knockout mice do not exhibit IP [108] whereas transgenic mice with cardiac-specific over-expression of PKCε or expression of an activator of PKCε are protected from reperfusion injury [109 111].

Expression of an activator of canonical Wnt signalling, Wnt-1, was found in a larger number of malignant EOC (29.4% out of a total 38, of which 22 were serous) compared with normal ovary (9.1% out of 26 total) specimens [ 65].

Interestingly, the INPP5F expression level correlated significantly with the expression of IKKb/IKBKB, an activator of NF-κB, and was inversely correlated to expression of IKBa, an inhibitor of NF-κB, suggesting an association between high expression of INPP5F and the activated NF-κB pathway and an agonistic AKT/PI3K function.

SbCO also increased expression of SbEHD1, an activator of Hd3a expression in rice.

FXR can also promote plasma VLDL triglyceride clearance by inducing the expression of ApoCII, an activator of lipoprotein lipase, and suppressing the expression of ApoCIII, an inhibitor of lipoprotein lipase activity (Mazuy et al., 2015, Fuchs et al., 2016).

The NHase enzyme contained its full complement of Co III) and was fully functional without the co-expression of an activator protein or E. coli GroES/EL molecular chaperones.

Expression of Wnt3a, an activator of canonical Wnt signaling, was indeed detected in CL6 cells exposed to DMSO, and BMP2 significantly down-regulated Wnt3a expression at day 3 (Fig. 4E).

This represents a feedback regulation on IIS, as dFoxO, an inhibitor in the IIS pathway, induces the expression of DILP6, an activator of IIS.

These include NEAT1, which encodes for a non-coding RNA and suppresses the expression of CIITA, an activator of genes within the major histocompatibility complex (MHC) class II locus.

Expression of matriptase (an activator of HGF) is positively correlated with both c-Met and HGF in invasive breast cancer, and high levels of c-Met and matriptase are associated with reduced 30-year survival at univariate analysis [ 38].